Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Coherus Oncology, Inc.CHRS · Entity 6276 | Director | June 03, 2024 | June 05, 2024 |
| RTI SURGICAL, INC.RTIX · Entity 159205 | Director | March 08, 2019 | March 11, 2019 |
| RadNet, Inc.RDNT · Entity 3800 | EVP, Chief Financial Officer | March 03, 2026 | March 05, 2026 |
| SURGALIGN HOLDINGS, INC.SRGA · Entity 109633 | Director | August 15, 2022 | August 17, 2022 |
| Starling Oncology, Inc.TOI · Entity 5327 | Director | July 27, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Coherus Oncology, Inc.
Report date June 03, 2024 · Filed June 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.76 · Expires 2034-06-03 | Direct | 112,000 |
Reported balance
After 2024-06-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-03 · Grant · Acquired 112,000 · Balance 112,000 F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.
RTI SURGICAL, INC.
Report date March 08, 2019 · Filed March 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 66,784 · Balance 0 F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers. F4: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc."
F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger.
F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers.
F4: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020.
RadNet, Inc.
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 121,943 |
Reported balance
After 2026-03-03 transaction · row 1
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 18,228 · Balance 121,943 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock. Amount reported is net of 1,060 restricted stock awards transferred pursuant to a domestic relations order. Subject to the reporting person's continued service, twenty-percent (20%) of the RSUs will vest on March 10, 2026; the remaining eighty-percent (80%) will vest in three equal annual installments with one-third (1/3) vesting on each of March 10, 2027, 2028, and 2029, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock. Amount reported is net of 1,060 restricted stock awards transferred pursuant to a domestic relations order. Subject to the reporting person's continued service, twenty-percent (20%) of the RSUs will vest on March 10, 2026; the remaining eighty-percent (80%) will vest in three equal annual installments with one-third (1/3) vesting on each of March 10, 2027, 2028, and 2029, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028.
SURGALIGN HOLDINGS, INC.
Report date August 15, 2022 · Filed August 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,867 |
Reported balance
After 2022-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-08-15 · Grant · Acquired 22,857 · Balance 28,867 F1: Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant.
F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022.
Starling Oncology, Inc.
Report date July 27, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,957 |
Reported balance
After 2026-07-27 transaction · row 1
1 source rowRow 1 · 2026-07-27 · Grant · Acquired 31,124 · Balance 56,957 F1: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2026 Filed Jul 29, 2026 22:52 UTC | Starling Oncology, Inc. TOI · Entity 5327 | GrantCommon Stock | 31,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001079973-26-000987 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,957 F1 · kind: Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 20:30 UTC | Starling Oncology, Inc. TOI · Entity 5327 | GrantCommon Stock | 25,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001079973-26-000939 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,833 F1 · kind: Represents RSU award that was fully vested upon grant. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 21:15 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantCommon Stock | 18,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001529 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,943 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock. Amount reported is net of 1,060 restricted stock awards transferred pursuant to a domestic relations order. Subject to the reporting person's continued service, twenty-percent (20%) of the RSUs will vest on March 10, 2026; the remaining eighty-percent (80%) will vest in three equal annual installments with one-third (1/3) vesting on each of March 10, 2027, 2028, and 2029, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:15 UTC | RadNet, Inc. RDNT · Entity 3800 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 35,703 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001683168-25-009105 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,703 shares Expires 2026-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On January 4, 2016, the reporting person was granted a stock option to purchase up to 35,703 shares of common stock of RadNet, Inc., subject to time-based vesting. Subject to the reporting person's continued service, the stock option vested in three equal annual installments, 1/3 on first anniversary of issuance and 1/3 on each anniversary thereafter. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:15 UTC | RadNet, Inc. RDNT · Entity 3800 | Exercise / conversionCommon Stock | 35,703 | $6.07 | $216,717.21 |
DisclosureSEC source: 0001683168-25-009105 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of previously granted option. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 21:29 UTC | RadNet, Inc. RDNT · Entity 3800 | SaleCommon Stock | 35,000 | $73.89 | $2,586,150.00 |
DisclosureSEC source: 0001683168-25-007119 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,012 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.51 to $74.57. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 22:47 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantCommon Stock | 22,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-25-000257 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,012 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock. Amount reported is net of 1,332 restricted stock awards transferred pursuant to a domestic relations order. Subject to the reporting person's continued service, twenty-percent (20%) of the RSUs will vest on March 10, 2025; the remaining eighty-percent (80%) will vest in three equal annual installments with one-third (1/3) vesting on each of March 10, 2026, 2027, and 2028, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 22:14 UTC | RadNet, Inc. RDNT · Entity 3800 | GiftCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-24-008817 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,123 F1 · price: Shares were transferred in a charitable donation. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:36 UTC | RadNet, Inc. RDNT · Entity 3800 | SaleCommon Stock | 25,000 | $61.27 | $1,531,750.00 |
DisclosureSEC source: 0001683168-24-004151 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,398 Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:49 UTC | Coherus Oncology, Inc. CHRS · Entity 6276 | GrantStock Option (Right to Buy) · Derivative | 112,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001610717-24-000289 · form4.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,000 Underlying: Common Stock · 112,000 shares Expires 2034-06-03 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 02:25 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee Stock Option (right to buy) · Derivative | 27,276 | $0.00 Strike: $18.64 | $0.00 |
DisclosureSEC source: 0001683168-24-001297 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,276 Underlying: Common Stock · 27,276 shares Expires 2033-01-02 F3 · shares: On January 3, 2023, the reporting person was granted a stock option to purchase up to 29,891 shares of Issuer common stock, subject to performance and time-based vesting. As a result of the Issuer's performance for fiscal year 2023, 100% of the shares subject to the option vested as to the performance-based vesting requirements and, subject to the reporting person's continued service, such performance vested option shares will vest as to the time-based vesting requirements in three equal annual installments on March 10, 2025, March 10, 2026, and March 10, 2027, respectively. F4 · shares: Amount reported is net of 2,615 option shares transferred pursuant to a domestic relations order. F3 · derivative.exercise_date: On January 3, 2023, the reporting person was granted a stock option to purchase up to 29,891 shares of Issuer common stock, subject to performance and time-based vesting. As a result of the Issuer's performance for fiscal year 2023, 100% of the shares subject to the option vested as to the performance-based vesting requirements and, subject to the reporting person's continued service, such performance vested option shares will vest as to the time-based vesting requirements in three equal annual installments on March 10, 2025, March 10, 2026, and March 10, 2027, respectively. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 02:25 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantCommon Stock | 14,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-24-001297 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,398 F1 · shares: On January 3, 2023, the reporting person was granted a target number of 7,711 restricted stock units ("RSUs"), subject to a domestic relations order and subject to performance and time-based vesting. On March 1, 2024 the Compensation Committee determined that based on the Issuer's fiscal year 2023 performance, 200% of the target number of RSUs vested on performance-based vesting requirements. The RSU's will vest in two equal annual installments on March 10, 2025 and March 10, 2026, respectively, subject to continued service. Each RSU represents the contingent right to receive one share of RDNT common stock. Vested RSUs will be settled for RDNT shares on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of the Issuer, or (iv) a future date(s) if so specified in the reporting person's deferral election. F2 · shares: Amount reported is net of 1,350 restricted stock units transferred pursuant to a domestic relations order. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 00:39 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 14,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-24-000203 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,558 Underlying: Common Stock · 14,558 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock. F2 · shares: Amount reported is net of 1,396 restricted stock units transferred pursuant to a domestic relations order. F3 · derivative.exercise_date: Subject to the reporting person's continued service, the RSU will vest in three equal annual installments with one-third vesting on March 10, 2024, and one-third vesting on each of March 10, 2025 and 2026, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028. F3 · derivative.expiration_date: Subject to the reporting person's continued service, the RSU will vest in three equal annual installments with one-third vesting on March 10, 2024, and one-third vesting on each of March 10, 2025 and 2026, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in equal annual installment payments over five years beginning on January 10, 2028. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:08 UTC | Coherus Oncology, Inc. CHRS · Entity 6276 | GrantStock Option (Right to Buy) · Derivative | 38,250 | $0.00 Strike: $5.38 | $0.00 |
DisclosureSEC source: 0001610717-23-000121 · form4.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,250 Underlying: Common Stock · 38,250 shares Expires 2033-06-07 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 12, 2023 Filed May 16, 2023 22:30 UTC | RadNet, Inc. RDNT · Entity 3800 | GiftCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-003479 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,326 Read SEC document |
| May 04, 2023 Filed May 9, 2023 00:39 UTC | RadNet, Inc. RDNT · Entity 3800 | GiftCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-003045 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,226 Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:22 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee Stock Option (right to buy) · Derivative | 4,854 | $0.00 Strike: $29.44 | $0.00 |
DisclosureSEC source: 0001683168-23-001258 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,854 Underlying: Common Stock · 4,854 shares Expires 2032-01-03 F5 · shares: Amount reported is net of 465 option shares transferred pursuant to a domestic relations order. F6 · derivative.exercise_date: On January 4, 2022, the reporting person was granted a stock option to purchase 21,275 shares of Issuer common stock, subject to a domestic relations order. The option vests upon (i) the achievement of certain performance criteria by the Issuer for fiscal year 2022, and (ii) satisfaction of time-based vesting conditions requiring the reporting person's continued service. As a result of the Issuer's performance for fiscal year 2022, 25% of the shares subject to the option vested as to the performance-based vesting requirements and, subject to the reporting person's continued service, such performance vested option shares will vest as to the time-based vesting requirements in three equal annual installments on January 4, 2024, January 4, 2025, and January 4, 2026, respectively. The performance vesting conditions for the RSUs and the stock option were the same. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 23:22 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 2,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-001258 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,227 Underlying: Common Stock · 2,227 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right, upon vesting of the RSU, to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · shares: Amount reported is net of 214 restricted stock units transferred pursuant to a domestic relations order. F3 · derivative.exercise_date: On January 4, 2022, the reporting person was granted a target number of 4,882 RSUs, subject to a domestic relations order, that vest upon (i) the achievement of certain performance criteria by the Issuer for fiscal year 2022, and (ii) satisfaction of time-based vesting conditions requiring the reporting person's continued service. As a result of the Issuer's performance for fiscal year 2022, 50% of the target number of RSUs vested as to the performance-based vesting requirements and, subject to the reporting person's continued service, such performance vested RSUs will vest as to the time-based vesting requirements in two equal annual installments on January 4, 2024 and January 4, 2025, respectively. F4 · derivative.exercise_date: The performance vesting conditions for the RSUs and the stock option were the same. RDNT shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of the Issuer, or (iv) in annual installment payments over five years beginning on January 10, 2028. F3 · derivative.expiration_date: On January 4, 2022, the reporting person was granted a target number of 4,882 RSUs, subject to a domestic relations order, that vest upon (i) the achievement of certain performance criteria by the Issuer for fiscal year 2022, and (ii) satisfaction of time-based vesting conditions requiring the reporting person's continued service. As a result of the Issuer's performance for fiscal year 2022, 50% of the target number of RSUs vested as to the performance-based vesting requirements and, subject to the reporting person's continued service, such performance vested RSUs will vest as to the time-based vesting requirements in two equal annual installments on January 4, 2024 and January 4, 2025, respectively. F4 · derivative.expiration_date: The performance vesting conditions for the RSUs and the stock option were the same. RDNT shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of the Issuer, or (iv) in annual installment payments over five years beginning on January 10, 2028. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:35 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee Stock Option (right to buy) · Derivative | 27,276 | $0.00 Strike: $18.64 | $0.00 |
DisclosureSEC source: 0001683168-23-000069 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,276 Underlying: Common Stock · 27,276 shares Expires 2033-01-02 F4 · shares: Amount reported is net of 2,615 option shares transferred pursuant to a domestic relations order. F5 · derivative.exercise_date: Subject to the reporting person's continued service, the option will vest as to one-third of the shares on March 10, 2023, one-third of the shares on March 10, 2024, and one-third of the shares on March 10, 2025, or the first business day thereafter if such date falls on a weekend or holiday, respectively. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 00:35 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 14,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-000069 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,073 Underlying: Common Stock · 14,073 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · shares: Amount reported is net of 1,350 restricted stock units transferred pursuant to a domestic relations order. F3 · derivative.exercise_date: Subject to the reporting person's continued service, the RSU will vest in two equal annual installments with one-half vesting on March 10, 2023 and one-half vesting on March 10, 2024, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in annual installment payments over five years beginning on January 10, 2028. F3 · derivative.expiration_date: Subject to the reporting person's continued service, the RSU will vest in two equal annual installments with one-half vesting on March 10, 2023 and one-half vesting on March 10, 2024, or the first business day thereafter if such date falls on a weekend or holiday, respectively. RDNT shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) the reporting person's death or disability, (iii) a change in control of RadNet, or (iv) in annual installment payments over five years beginning on January 10, 2028. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 16:42 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 22,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-046165 · doc4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,867 F1 · shares: Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. F2 · balance_after: The total shares reported reflect 1:30 reverse stock split on May 17, 2022. Read SEC document |
| January 07, 2022 Filed Jan 10, 2022 21:32 UTC | Coherus Oncology, Inc. CHRS · Entity 6276 | GrantStock Option (Right to Buy) · Derivative | 27,000 | $0.00 Strike: $15.94 | $0.00 |
DisclosureSEC source: 0001567619-22-000924 · doc1.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2032-01-07 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 07, 2022 Filed Feb 11, 2022 21:13 UTC Amendment | Coherus Oncology, Inc. CHRS · Entity 6276 | GrantStock Option (Right to Buy) · Derivative | 27,000 | $0.00 Strike: $14.67 | $0.00 |
DisclosureSEC source: 0001567619-22-003508 · doc1.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2032-01-07 F1 · derivative.exercise_price: The Form 4/A is being filed solely to correct a typographical error in the exercise price. Except as noted in this footnote, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported. F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 00:06 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee stock option (right to buy) · Derivative | 10,635 | $0.00 Strike: $29.44 | $0.00 |
DisclosureSEC source: 0001683168-22-000159 · ownership.xml · derivative · entry 4 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,635 Underlying: Common Stock · 10,635 shares Expires 2032-01-03 Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 00:06 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee stock option (right to buy) · Derivative | 29,140 | $0.00 Strike: $29.44 | $0.00 |
DisclosureSEC source: 0001683168-22-000159 · ownership.xml · derivative · entry 3 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,140 Underlying: Common Stock · 29,140 shares Expires 2032-01-03 F4 · derivative.exercise_date: The option vested as to one-third of the shares on January 4, 2022, and will vest with respect to the remaining two-thirds of the shares, subject to the reporting person's continued service, in three equal annual installments on January 3, 2023, January 3, 2024, and January 3, 2025. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 00:06 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 4,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-22-000159 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,882 Underlying: Common Stock · 4,882 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F3 · derivative.exercise_date: The RSU will vest on January 3, 2023. RDNT shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) death or disability, (iii) a change in control of RadNet, or (iv) in annual installments over five years, commencing on January 1, 2027. The vesting of RSUs may be accelerated under certain circumstances. F3 · derivative.expiration_date: The RSU will vest on January 3, 2023. RDNT shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, (ii) death or disability, (iii) a change in control of RadNet, or (iv) in annual installments over five years, commencing on January 1, 2027. The vesting of RSUs may be accelerated under certain circumstances. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 00:06 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 13,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-22-000159 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,374 Underlying: Common Stock · 13,374 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The RSU vested as to one-third of the shares on January 4, 2022, and will vest with respect to the remaining two-thirds of the shares, subject to the reporting person's continued service, in two equal annual installments on January 3, 2023 and January 3, 2024. F2 · derivative.expiration_date: The RSU vested as to one-third of the shares on January 4, 2022, and will vest with respect to the remaining two-thirds of the shares, subject to the reporting person's continued service, in two equal annual installments on January 3, 2023 and January 3, 2024. Read SEC document |
| September 21, 2021 Filed Sep 25, 2021 01:22 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-21-004493 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Underlying: Common Stock · 2,410 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The RSUs are fully vested. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) September 21, 2026. The vesting of RSUs may also be accelerated under certain circumstances. F2 · derivative.expiration_date: The RSUs are fully vested. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) September 21, 2026. The vesting of RSUs may also be accelerated under certain circumstances. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:56 UTC | Coherus Oncology, Inc. CHRS · Entity 6276 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $13.48 | $0.00 |
DisclosureSEC source: 0001567619-21-011154 · doc1.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-21 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 21, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:23 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 57,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031329 · doc4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,946 F1 · shares: Represents restricted stock units of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. Read SEC document |
| May 07, 2021 Filed Jul 2, 2021 20:48 UTC Amendment | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | GrantCommon Stock | 72,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045021 · doc4a.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,397 F1 · shares: The Form 4 filed on 5/10/2021 representing restricted stock units of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant erroneously reported 57,803 RSUs in column four. The purpose of this amendment is to correct the total underlying shares in columns four and five. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 15:43 UTC | SURGALIGN HOLDINGS, INC. SRGA · Entity 109633 | PurchaseCommon Stock | 16,667 | $1.50 | $25,000.50 |
DisclosureSEC source: 0001209191-21-006640 · doc4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,143 Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:32 UTC | Coherus Oncology, Inc. CHRS · Entity 6276 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001567619-21-000738 · doc1.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-01-05 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from January 5, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 01:59 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 19,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-21-000050 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,317 Underlying: Common Stock · 19,317 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · shares: Amount reported is net of 1,852 restricted stock awards transferred pursuant to a domestic relations order. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments with the first such vesting installment occurring on January 4, 2021. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 4, 2026. The vesting of RSUs may also be accelerated under certain circumstances. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments with the first such vesting installment occurring on January 4, 2021. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 4, 2026. The vesting of RSUs may also be accelerated under certain circumstances. Read SEC document |
| February 26, 2020 Filed Mar 2, 2020 18:40 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantCommon Stock | 24,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014370 · doc4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,476 F1 · shares: Represents shares of restricted stock of RTI Surgical Holdings, Inc. (the "Company") granted to Mr. Stolper as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. Read SEC document |
| January 06, 2020 Filed Jan 11, 2020 02:14 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee Stock Option (right to buy) · Derivative | 11,625 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001683168-20-000093 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,354 Underlying: Common Stock · 11,625 shares Expires 2030-01-06 F2 · derivative.exercise_date: Issued in connection with retention of employment. Vests in three equal annual installments with such vesting occurring on January 6, 2021, January 6, 2022, and January 6, 2023, respectively. The vesting of the stock option may also be accelerated under certain circumstances. Read SEC document |
| January 06, 2020 Filed Jan 11, 2020 02:14 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantCommon Stock | 11,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-20-000093 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,239 F1 · price: Issued in connection with retention of employment. Vests in three equal annual installments with such vesting occurring on January 6, 2020, January 6, 2021, and January 6, 2022, respectively. The vesting of the common stock may also be accelerated under certain circumstances. Read SEC document |
| January 06, 2020 Filed May 9, 2023 00:39 UTC Amendment | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee Stock Option (right to buy) · Derivative | 11,625 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001683168-23-003046 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,354 Underlying: Common Stock · 11,625 shares Expires 2030-01-06 F4 · derivative.exercise_date: Issued in connection with retention of employment. Vests in three equal annual installments with such vesting occurring on January 6, 2021, January 6, 2022, and January 6, 2023, respectively. The vesting of the stock option may also be accelerated under certain circumstances. Read SEC document |
| January 06, 2020 Filed May 9, 2023 00:39 UTC Amendment | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 10,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-003046 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,607 Underlying: Common Stock · 10,607 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · shares: Amount reported is net of 1,018 restricted stock awards transferred pursuant to a domestic relations order. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments with the first such vesting installment occurring on January 6, 2021. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 6, 2025. The vesting of RSUs may also be accelerated under certain circumstances. F3 · derivative.expiration_date: The RSUs vest in three equal annual installments with the first such vesting installment occurring on January 6, 2021. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 6, 2025. The vesting of RSUs may also be accelerated under certain circumstances. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 16:09 UTC | RadNet, Inc. RDNT · Entity 3800 | SaleCommon Stock | 20,703 | $15.15 | $313,650.45 |
DisclosureSEC source: 0001683168-19-002661 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,614 F1 · balance_after: This amount also reflects a reduction by two shares to correct the previously reported total number of shares benefically owned. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 19:41 UTC | RadNet, Inc. RDNT · Entity 3800 | SaleCommon Stock | 15,000 | $14.99 | $224,895.00 |
DisclosureSEC source: 0001683168-19-000733 · ownership.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,317 F1 · balance_after: This amount also reflects a reduction by two shares to correct the previously reported total number of shares beneficially owned. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 13:05 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | Disposition to issuerCommon Stock | 66,784 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001100441-19-000008 · primary_doc.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2 · price: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3 · price: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers. F4 · price: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 17:11 UTC | SURGALIGN HOLDINGS, INC. RTIX · Entity 109633 | GrantCommon Stock | 66,784 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001760173-19-000022 · primary_doc.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,784 F1 · price: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2 · price: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3 · price: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 14:43 UTC | RTI SURGICAL, INC. RTIX · Entity 159205 | GrantCommon Stock | 21,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001100441-19-000001 · primary_doc.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,784 F1 · shares: Represents shares of restricted stock of RTI Surgical, Inc.(the "Company") granted to Mr. Stolper as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. Read SEC document |
| January 07, 2019 Filed Jan 15, 2019 20:25 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee Stock Option (right to buy) · Derivative | 21,729 | $0.00 Strike: $10.93 | $0.00 |
DisclosureSEC source: 0001683168-19-000105 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,729 Underlying: Common Stock · 21,729 shares Expires 2029-01-06 F3 · derivative.exercise_date: The stock option vests in three equal annual installments with the first such vesting installment occurring on January 7, 2019. The vesting of the stock option may also be accelerated under certain circumstances. Read SEC document |
| January 07, 2019 Filed Jan 15, 2019 20:25 UTC | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 21,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000105 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,729 Underlying: Common Stock · 21,729 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments with the first such vesting installment occurring on January 7, 2020. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 7, 2024. The vesting of RSUs may also be accelerated under certain circumstances. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments with the first such vesting installment occurring on January 7, 2020. RDNT Shares (and/or cash) will be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 7, 2024. The vesting of RSUs may also be accelerated under certain circumstances. Read SEC document |
| January 07, 2019 Filed Mar 5, 2019 17:27 UTC Amendment | RadNet, Inc. RDNT · Entity 3800 | GrantEmployee Stock Option (right to buy) · Derivative | 21,729 | $0.00 Strike: $10.93 | $0.00 |
DisclosureSEC source: 0001683168-19-000552 · ownership.xml · derivative · entry 2 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,729 Underlying: Common Stock · 21,729 shares Expires 2029-01-07 F3 · derivative.exercise_date: The stock option vests in three equal annual installments with such vesting occurring on January 7, 2020, January 7, 2021, and January 7, 2022, respectively. The vesting of the stock option may also be accelerated under certain circumstances. Read SEC document |
| January 07, 2019 Filed Mar 5, 2019 17:27 UTC Amendment | RadNet, Inc. RDNT · Entity 3800 | GrantRestricted Stock Units · Derivative | 21,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000552 · ownership.xml · derivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,729 Underlying: Common Stock · 21,729 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of RDNT common stock and/or the cash equivalent of such share. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments with such vesting occurring on January 7, 2019, January 7, 2020, and January 7, 2021, respectively. RDNT Shares (and/or cash) will generally be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 7, 2024. The vesting of RSUs may also be accelerated under certain circumstances. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments with such vesting occurring on January 7, 2019, January 7, 2020, and January 7, 2021, respectively. RDNT Shares (and/or cash) will generally be delivered to the reporting person in exchange for vested RSUs on the earlier of (i) the reporting person's separation from service, death or disability, (ii) a change in control of RDNT, or (iii) January 7, 2024. The vesting of RSUs may also be accelerated under certain circumstances. Read SEC document |
| April 11, 2018 Filed Apr 11, 2018 20:33 UTC | RadNet, Inc. RDNT · Entity 3800 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-000971 · stolper_frm4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,319 Read SEC document |
| March 20, 2018 Filed Mar 20, 2018 22:58 UTC | RadNet, Inc. RDNT · Entity 3800 | SaleCommon Stock | 15,000 | $13.19 | $197,850.00 |
DisclosureSEC source: 0001683168-18-000730 · stolper_frm4.xml · nonDerivative · entry 1 STOLPER MARK · CIK 0001281961 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,319 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.